Citations

Clear

3030 citation(s) found for "Susan, M".

Abstract 2722: The genomic landscape of high-grade serous ovarian cancer in long-term survivors
Garsed, Dale W. , Beach, Jessica A. , Hendley, Joy , Pearce, Celeste Leigh , Pike, Malcolm C. , Group, Multidisciplinary Ovarian Cancer Outcomes, Goode, Ellen L. , Garsed, Dale W , Pandey, Ahwan , Fereday, Sián , Alsop, Kathryn , Wouters, Maartje C.A. , Saner, Flurina A.M. , Milne, Katy , Kennedy, Catherine J. , Traficante, Nadia , Group, Multidisciplinary Ovarian Cancer Outcomes, Ramus, Susan J. , Köbel, Martin , Nelson, Brad H. , DeFazio, Anna , Bowtell, David D.L.

Mayo Clinic

Cancer Research | August 7, 2019 | Volume: 79 | Issue: 13_Supplement | Pages: 2722-2722

10.1158/1538-7445.am2019-2722 Get It

Abstract Purpose: The majority of patients with high-grade serous ovarian cancer (HGSC) develop progressive disease following primary treatment, with a five-year survival rate of ~30%. However, a subset of patients have an extraordinary response to treatment and ~15% survive more than ten years (long-term survivors). The Multidisciplinary Ovarian Cancer Outcomes Group (MOCOG) aims to uncover factors that influence long-term survival of HGSC patients. Here, we investigated the genomic and immunologic determinants of exceptional survival of this deadly disease. Experimental Design: Patient characteristics and clinical histories were evaluated to identify patients diagnosed with advanced stage (Stage IIIC/IV) and histopathologically confirmed HGSC with greater than 10-year overall survival. Whole-genome sequencing (WGS) was performed on primary tumors (median 78x coverage) and germline samples (median 39x coverage) of 55 long-term survivors. Primary tumor samples were also characterised by RNA sequencing, DNA methylation profiling and immunohistochemistry. Results: A total 38 (69%) of long-term surviving patients had residual disease following surgery, suggestive of highly chemo-sensitive disease. Most patients (41, 75%) were alive at last follow-up and 26 (47%) were progression-free. Somatic mutation burden was higher in primary tumors of long-term survivors relative to controls (316 unselected HGSC patients in The Cancer Genome Atlas). Genome-wide mutational signatures were predominantly Signature 3 (associated with homologous recombination deficiency), Signature 1 (age related) and Signatures 5, 8 and 16 (unknown etiology). Inactivation of the tumor suppressor RB1 by structural rearrangements or homozygous deletion was frequent in long-term survivors, with 33% of tumors showing associated loss of RB1 protein expression by immunohistochemistry compared to 13% of unselected HGSC controls (n=207; P = 0.001). Staining of adjacent tumor tissue revealed that RB1 loss was associated with increased numbers of PD-1+ tumor-infiltrating lymphocytes (P = 0.015) and MHC class I on tumor cells (P = 0.002). In an independent HGSC cohort (n=847), RB1 protein loss was associated with prolonged survival (HR: 0.75, P < 0.001) compared to patients with RB1 positive tumors. Furthermore, co-occurrence of germline mutations in BRCA1 or BRCA2 and RB1 loss was associated with a significantly longer overall survival compared to patients with retained RB1 protein expression and no germline BRCA mutation (HR: 0.44, P < 0.001). Conclusions: This study delineates the full landscape of genomic alterations in HGSC of long-term survivors. Our findings indicate that specific mutations might be associated with enhanced host immune responses and long-term survival. Citation Format: Dale W. Garsed, Ahwan Pandey, Sian Fereday, Kathryn Alsop, Maartje C. Wouters, Flurina Saner, Jessica A. Beach, Katy Milne, Catherine J. Kennedy, Joy Hendley, Nadia Traficante, Celeste L. Pearce, Malcolm C. Pike, Multidisciplinary Ovarian Cancer Outcomes Group, Susan J. Ramus, Martin Köbel, Brad H. Nelson, Ellen L. Goode, Anna deFazio, David D. Bowtell. The genomic landscape of high-grade serous ovarian cancer in long-term survivors [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2722.
Abstract 2686: Associations between a polygenic risk score and risk of multiple myeloma and its precursor
Clay‐Gilmour, Alyssa , Camp, Nicola J. , Brown, Elizabeth E. , Spinelli, John J. , Wu, Xifeng , Robinson, Dennis P. , Kumar, Shaji , Vachon, Celine M. , Hildebrandt, Michelle A.T. , Ziv, Elad , Hofmann, Jonathan N. , Giles, Graham G. , Bhatti, Parveen , Cozen, Wendy , Norman, Aaron D. , Sinnwell, Jason P. , Rajkumar, S. Vincent , Slager, Susan L. , Vachon, Celine M.

Mayo Clinic

Cancer Research | August 7, 2019 | Volume: 79 | Issue: 13_Supplement | Pages: 2686-2686

10.1158/1538-7445.am2019-2686 Get It

Abstract Genome-wide association studies (GWAS) conducted among populations of European ancestry (EA) have identified 23 common single nucleotide polymorphisms (SNPs) associated with multiple myeloma (MM) risk. We hypothesize that the combination of these SNPs in a polygenic risk score (PRS) is likely to be a strong risk factor for MM. However, it is unclear whether the genetic variation associated with MM susceptibility also predisposes to monoclonal gammopathy of undetermined significance (MGUS). Thus, we calculated a PRS and evaluated the association with risk of MM and its precursor, MGUS. We pooled genotype data for 2434 MM and 3446 controls from ten MM GWAS of individuals of EA within the Interlymph Consortium, for 23 MM risk SNPs identified by prior GWAS. An additional 754 MGUS cases were ascertained from Mayo Clinic and MD Anderson clinical practices. To calculate the PRS, we used the risk estimates corresponding to the 23 SNP associations from the largest published MM GWAS. The log of the odds ratio (OR) for each SNP was multiplied by the respective number of risk alleles and summed to generate a PRS for each individual. The PRS was examined continuously, per one standard deviation (SD), and as quintiles, based on the PRS distribution in the controls. Associations of PRS with MM and MGUS risk were examined separately, using multivariable logistic regression assuming an additive model to assess ORs and 95% confidence intervals adjusted for age, sex, and site. We also evaluated age and sex stratified models. The distribution of sex within MM cases, MGUS cases and controls were each ~60% male and ~40% female. The median age was 61, 66, and 66 years for MM cases, MGUS cases and controls, respectively. PRS ranged from 1.52-4.91, with a median PRS of 3.21 for MM cases, 3.19 for MGUS cases, and 3.05 for controls. PRS was significantly associated with MM risk when assessed continuously (OR=1.19 per SD, p=2.2x10-16) and categorically; compared with the middle quintile (Q3), individuals in the highest quintile (Q5) had a 66% increased MM risk (OR=1.66, p=2.3x10-9) and those in the lowest quintile (Q1) had a 38% decreased MM risk (OR=0.62, p=1.3x10-6). PRS was also significantly associated with MGUS risk (OR=1.19 per SD, p=1.7x10-11); individuals with the highest PRS (Q5) had a 77% increased risk (OR=1.77, p=4.0x10-4) and those with lowest PRS (Q1) had 30% decreased risk (OR=0.70, p=0.04), compared with Q3. When stratified by age and sex, similar associations and trends were found. Using an independent sample of MM / MGUS cases and controls, we showed that a PRS constructed from 23 common genetic variants for MM risk is associated with risk of both MM and MGUS, regardless of age or sex. A future direction of this work is testing associations with PRS and clinical characteristics of the MM cases, as well as differences between MGUS cases that progress and those that do not. Our results suggest that common genetic variation may predispose to MGUS as the precursor to MM. Citation Format: Alyssa I. Clay-Gilmour, Michelle A. Hildebrandt, Nicola J. Camp, Elad Ziv, Elizabeth E. Brown, Jonathan N. Hofmann, John J. Spinelli, Graham G. Giles, Parveen Bhatti, Wendy Cozen, Xifeng Wu, Dennis P. Robinson, Aaron D. Norman, Jason P. Sinnwell, Shaji K. Kumar, S Vincent Rajkumar, Susan L. Slager, Celine M. Vachon. Associations between a polygenic risk score and risk of multiple myeloma and its precursor [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2686.
Work-Related Musculoskeletal Discomfort and Injury in Craniofacial and Maxillofacial Surgeons
Howarth, Ashley L. , Lemaine, Valérie, Singh, Davinder , Noland, Shelley S. , Singh, Davinder J , Hallbeck, M. Susan

Mayo Clinic

Journal of Craniofacial Surgery | August 1, 2019 | Volume: 30 | Issue: 7 | Pages: 1982-1985

10.1097/scs.0000000000005631 | PMID 31369503 Get It

Introduction: Long, complex surgical procedures with non-ergonomic postures, headlights, loupe magnification, and microscope use may put craniofacial and maxillofacial surgeons at an increased risk of work-related musculoskeletal discomfort (WRMD). Identifying the prevalence and impact of WRMD may guide preventive strategies to prolong well-being, job satisfaction, and career duration. Methods: A 31-question survey was designed to evaluate WRMD. The survey was sent to American Society of Craniofacial Surgeons and American Society of Maxillofacial Surgeons members. The survey was created and distributed electronically through a private survey research center (Qualtrics Survey Software). Results: There were 95 respondents (23.75% response rate): 75% male, 56% aged 31 to 50 years old, and 73% in academic practice. On a scale of 0 to 10 (0 no pain, 10 worst pain), WRMD for surgery without loupes/microscope had a median of 3, with loupes 4, and with microscope 5. Pain was most common in the neck. Pain within 4 hours of surgery was present in 55% and 38% feared pain would influence future surgical performance. Surgeon discomfort affects posture (72%), stamina (32%), sleep (28%), surgical speed (24%), relationships (18%), and concentration (17%). Medical treatment for discomfort was sought by 22%. Time off work for treatment occurred in 9%. Conclusion: The WRMD can affect many aspects of a craniofacial or maxillofacial surgeon's life and has the potential to shorten or end a career. Occupational health and surgical ergonomics should be emphasized during surgical training and in surgical practice.
Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma
Wang, Yucai , Link, Brian K. , Witzig, Thomas E. , Maurer, Matthew J. , Allmer, Cristine, King, Rebecca L. , Feldman, Andrew L. , Ansell, Stephen M. , Nowakowski, Grzegorz S. , Witzig, T.E. , Feldman, Andrew L , Maurer, Matthew , Link, Brian K , Wang, Yucai , Habermann, Thomas M. , Slager, Susan L. , Cerhan, James R.

Mayo Clinic

Blood | July 26, 2019 | Volume: 134 | Issue: 16 | Pages: 1289-1297

10.1182/blood.2019000858 | PMID 31350266 Get It

Abstract In this month's CME article, an analysis of over 1300 patients with diffuse large B-cell lymphoma (DLBCL), Wang et al demonstrate that the approximately 13% of patients with concurrent indolent lymphoma at diagnosis had the same prognosis as those patients with isolated DLBCL.
ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma
Johnston, Sandra K. , Whitmire, Paula , Kumthekar, Priya , Porter, Alyx B. , Raghunand, Natarajan , Gonzalez‐Cuyar, Luis F. , Mrugała, Maciej M. , Hu, Leland , Wang, Lei , Egan, Kathleen M. , Canoll, Peter , Swanson, Kristin R. , Swanson, Kristin R , Massey, Susan Christine , Hawkins‐Daarud, Andrea , Jackson, Pamela , Sarkaria, Jann N. , Gatenby, Robert A.

Mayo Clinic

American Journal of Clinical Oncology | July 24, 2019 | Volume: 42 | Issue: 8 | Pages: 655-661

10.1097/coc.0000000000000564 | PMID 31343422 Get It

Although glioblastoma (GBM) is a fatal primary brain cancer with short median survival of 15 months, a small number of patients survive >5 years after diagnosis; they are known as extreme survivors (ES). Because of their rarity, very little is known about what differentiates these outliers from other patients with GBM. For the purpose of identifying unknown drivers of extreme survivorship in GBM, the ENDURES consortium (ENvironmental Dynamics Underlying Responsive Extreme Survivors of GBM) was developed. This consortium is a multicenter collaborative network of investigators focused on the integration of multiple types of clinical data and the creation of patient-specific models of tumor growth informed by radiographic and histologic parameters. Leveraging our combined resources, the goals of the ENDURES consortium are 2-fold: (1) to build a curated, searchable, multilayered repository housing clinical and outcome data on a large cohort of ES patients with GBM; and (2) to leverage the ENDURES repository for new insights into tumor behavior and novel targets for prolonging survival for all patients with GBM. In this article, the authors review the available literature and discuss what is already known about ES. The authors then describe the creation of their consortium and some preliminary results.
Type 8 long QT syndrome: pathogenic variants in CACNA1C-encoded Cav1.2 cluster in STAC protein binding site
Mellor, Greg , Panwar, Pankaj, Lee, Andrea K, Hathaway, Julie , Bartels, Kirsten , Balaji, Seshadri , Roberts, Jason D. , Simpson, Chris S., Boczek, Nicole J. , Tester, David J. , Radbill, Andrew E. , Mok, Ngai‐Shing, Hamilton, Robert M. , Kaufman, Elizabeth S. , Eugenio, Paul, January, Craig T., McDaniel, George, Leather, Richard, Falik, Shelley, Behr, Elijah R. , Wilde, Arthur A.M. , Sanatani, Shubhayan , Ackerman, Michael J. , Petegem, Filip Van , Laksman, Zachary , Behr, Elijah Raphael , Sanatani, Shubhayan , Hamilton, Robert , Steinberg, Christian , Christian, Susan , Weiss, Raul , Erickson, Christopher, Krahn, Andrew D.

Mayo Clinic

EP Europace | July 24, 2019 | Volume: 21 | Issue: 11 | Pages: 1725-1732

10.1093/europace/euz215 | PMID 31408100 Get It

Abstract Aims Pathogenic gain-of-function variants in CACAN1C cause type-8 long QT syndrome (LQT8). We sought to describe the electrocardiographic features in LQT8 and utilize molecular modelling to gain mechanistic insights into its genetic culprits. Methods and results Rare variants in CACNA1C were identified from genetic testing laboratories. Treating physicians provided clinical information. Variant pathogenicity was independently assessed according to recent guidelines. Pathogenic (P) and likely pathogenic (LP) variants were mapped onto a 3D modelled structure of the Cav1.2 protein. Nine P/LP variants, identified in 23 patients from 19 families with non-syndromic LQTS were identified. Six variants, found in 79% of families, clustered to a 4-residue section in the cytosolic II–III loop region which forms a region capable of binding STAC SH3 domains. Therefore, variants may affect binding of SH3-domain containing proteins. Arrhythmic events occurred in similar proportions of patients with II–III loop variants and with other P/LP variants (53% vs. 48%, P = 0.41) despite shorter QTc intervals (477 ± 31 ms vs. 515 ± 37 ms, P = 0.03). A history of sudden death was reported only in families with II–III loop variants (60% vs. 0%, P = 0.03). The predominant T-wave morphology was a late peaking T wave with a steep descending limb. Exercise testing demonstrated QTc prolongation on standing and at 4 min recovery after exercise. Conclusion The majority of P/LP variants in patients with CACNA1C-mediated LQT8 cluster in an SH3-binding domain of the cytosolic II–III loop. This represents a ‘mutation hotspot’ in LQT8. A late-peaking T wave with a steep descending limb and QT prolongation on exercise are commonly seen.
Guidelines for neuromuscular ultrasound training
Tawfik, Eman A. , Cartwright, Michael S. , Grimm, Alexander , Boon, Andrea J. , Kerasnoudis, Antonios , Preston, David C. , Wilder‐Smith, Einar , Axer, Hubertus , Hobson‐Webb, Lisa D., Crump, Nicholas , Shahrizaila, Nortina , Inkpen, Peter, Mandeville, Ross , Sakamuri, Sarada, Shook, Steven J. , Shin, Susan , Walker, Francis O. , Crump, Nicholas , Shin, Susan , Alfen, Nens van

Mayo Clinic

Muscle & Nerve | July 23, 2019 | Volume: 60 | Issue: 4 | Pages: 361-366

10.1002/mus.26642 | PMID 31335971 Get It

AbstractNeuromuscular ultrasound has become an essential tool in the diagnostic evaluation of various neuromuscular disorders, and, as such, there is growing interest in neuromuscular ultrasound training. Effective training is critical in mastering this modality. Our aim was to develop consensus‐based guidelines for neuromuscular ultrasound training courses. A total of 18 experts participated. Expert opinion was sought through the Delphi method using 4 consecutive electronic surveys. A high degree of consensus was achieved with regard to the general structure of neuromuscular ultrasound training; the categorization of training into basic, intermediate, and advanced levels; the learning objectives; and the curriculum for each level. In this study, a group of neuromuscular ultrasound experts established consensus‐based guidelines for neuromuscular ultrasound training. These guidelines can be used in the development of the specialty and the standardization of neuromuscular ultrasound training courses and workshops.
Profiling Multiscale Frequency State of Normal Phonocardiogram: Feasibility Study
Sundaram, Divaakar Siva Baala, Anjani, Muthyala, Balasubramani, Rogith, Shivaram, Suganti, Karki, Susan, Arunachalam, S P , Karki, Susan, Arunachalam, Shivaram P.

Mayo Clinic

2019 Design of Medical Devices Conference | July 19, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1115/dmd2019-3301 Get It

Phonocardiogram (PCG) signals contain very important information regarding the heart condition. Recently, several automatic detection algorithms have been explored to profile the characteristics of heart sounds to aid in disease diagnosis. However, many of these methods has been demonstrated only on clean signals with limited test data and variety of PCG signals that can accurately provide information of diagnostic importance with higher sensitivity and specificity. In this work, we propose to characterize the multiscale frequency state of the normal PCG signals that can aid in accurate profiling of PCG to discriminate from pathological conditions.